Edwards Lifesciences Corp [NYSE: EW] traded at a high on 2025-07-10, posting a 2.09 gain after which it closed the day’ session at $78.8.
The results of the trading session contributed to over 4265478 shares changing hands. Over the past one week, the price volatility of Edwards Lifesciences Corp stands at 1.75% while the volatility over the past one month is 1.90%.
The market cap for EW stock reached $46.22 billion, with 586.20 million shares outstanding and 574.69 million shares in the current float. Compared to the average trading volume of 4.23M shares, EW reached a trading volume of 4265478 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Edwards Lifesciences Corp [EW]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EW shares is $81.46 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EW stock is a recommendation set at 2.16. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Edwards Lifesciences Corp shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 24, 2025. While these analysts kept the previous recommendation, Stifel raised their target price from $75 to $90. The new note on the price target was released on January 30, 2025, representing the official price target for Edwards Lifesciences Corp stock. Previously, the target price had yet another raise to $60, while Wolfe Research analysts kept a Underperform rating on EW stock.
The Price to Book ratio for the last quarter was 4.56, with the Price to Cash per share for the same quarter was set at 6.65. Price to Free Cash Flow for EW in the course of the last twelve months was 73.01 with Quick ratio for the last quarter at 3.66.
How has EW stock performed recently?
Edwards Lifesciences Corp [EW] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.31. With this latest performance, EW shares gained by 3.20% in over the last four-week period, additionally plugging by 7.15% over the last 6 months – not to mention a rise of 6.44% in the past year of trading.
Edwards Lifesciences Corp [EW]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Edwards Lifesciences Corp [EW] shares currently have an operating margin of 26.92% and a Gross Margin at 78.59%. Edwards Lifesciences Corp’s Net Margin is presently recorded at 16.03%.
Return on Equity for this stock inclined to 12.68%, with Return on Assets sitting at 12.68%.
Earnings analysis for Edwards Lifesciences Corp [EW]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EW. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Edwards Lifesciences Corp go to 8.56%.
Insider trade positions for Edwards Lifesciences Corp [EW]
There are presently around $89.29%, or 90.12% of EW stock, in the hands of institutional investors. The top three institutional holders of EW stocks are: VANGUARD GROUP INC with ownership of 53.58 million shares, which is approximately 8.8982%. BLACKROCK INC., holding 50.98 million shares of the stock with an approximate value of $$4.71 billion in EW stocks shares; and BLACKROCK INC., currently with $$2.4 billion in EW stock with ownership which is approximately 4.3197%.
